Kidney failure with replacement therapy (KFRT) such as dialysis or transplantation represents a severe stage of chronic kidney disease (CKD) and poses a major global health burden. Although many CKD ...

The endothelium is considered to be the gatekeeper of the vessel wall, maintaining and regulating vascular integrity. In patients with chronic kidney disease, protective endothelial cell functions are ...

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients 12 years and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

Apellis's Empaveli is the first drug to reach the IC-MPGN market and will compete against Novartis' Fabhalta in C3G, another rare kidney disease.

Before receiving her transplant from a living donor, LaQuayia "LQ" Goldring spent up to four and a half hours a day hooked up to a home dialysis machine.

A phase 2 trial of Memo’s kidney transplant drug candidate has missed its primary endpoint, adding to the list of setbacks in the indication.

The Moneyist I have early Alzheimer’s and my husband has stage 4 kidney disease. We just inherited $50K. How can this help us? ‘We have a 401 (k) with $20,000, and $29,000 in a Roth IRA’ ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

Keywords: chronic kidney disease, diabetes mellitus, epidemiology, global burden of disease study, glomerulonephritis, hypertension, risk factors Citation: Wang L, He Y, Han C, Zhu P, Zhou Y, Tang R ...